Literature DB >> 22062497

Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning.

Michael D Burton1, Rodney W Johnson.   

Abstract

Excessive production of pro-inflammatory cytokines in the senescent brain in response to peripheral immune stimulation is thought to induce behavioral pathology, however, few studies have examined if the increase in pro-inflammatory cytokines is accompanied by an increase in cytokine signaling. Here, we focused on IL-6 as a prototypic pro-inflammatory cytokine and used phosphorylated STAT3 as a marker of IL-6 signaling. In an initial study, IL-6 mRNA and the magnitude and duration of STAT3 activation were increased in the hippocampus of senescent mice compared to adults after i.p. injection of LPS. The LPS-induced increase in STAT3 activity was ablated in aged IL-6(-/-) mice, suggesting IL-6 is a key driver of STAT3 activity in the aged brain. To determine if IL-6 activated the classical or trans-signaling pathway, before receiving LPS i.p., aged mice were injected ICV with sgp130, an antagonist of the trans-signaling pathway. Importantly, the LPS-induced increases in both IL-6 and STAT3 activity in the hippocampus were inhibited by sgp130. To assess hippocampal function, aged mice were injected ICV with sgp130 and i.p. with LPS immediately after the acquisition phase of contextual fear conditioning, and immobility was assessed in the retention phase 48h later. LPS reduced immobility in aged mice, indicating immune activation interfered with memory consolidation. However, sgp130 blocked the deficits in contextual fear conditioning caused by LPS. Taken together, the results suggest IL-6 trans-signaling is increased in the senescent brain following peripheral LPS challenge and that sgp130 may protect against infection-related neuroinflammation and cognitive dysfunction in the aged.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22062497      PMCID: PMC3699311          DOI: 10.1016/j.bbi.2011.10.008

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  52 in total

Review 1.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

2.  Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis.

Authors:  Peter J Richards; Mari A Nowell; Sankichi Horiuchi; Rachel M McLoughlin; Ceri A Fielding; Sandra Grau; Naoki Yamamoto; Michael Ehrmann; Stefan Rose-John; Anwen S Williams; Nicholas Topley; Simon A Jones
Journal:  Arthritis Rheum       Date:  2006-05

3.  Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers.

Authors:  Nathan L Sparkman; Jessica B Buchanan; Jonathan R R Heyen; Jing Chen; James L Beverly; Rodney W Johnson
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

4.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

Authors:  Rachel M McLoughlin; Brendan J Jenkins; Dianne Grail; Anwen S Williams; Ceri A Fielding; Clare R Parker; Matthias Ernst; Nicholas Topley; Simon A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

5.  Peripheral infection and aging interact to impair hippocampal memory consolidation.

Authors:  Ruth M Barrientos; Emily A Higgins; Joseph C Biedenkapp; David B Sprunger; Karli J Wright-Hardesty; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Neurobiol Aging       Date:  2006-05       Impact factor: 4.673

6.  Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system.

Authors:  J P Godbout; J Chen; J Abraham; A F Richwine; B M Berg; K W Kelley; R W Johnson
Journal:  FASEB J       Date:  2005-05-26       Impact factor: 5.191

Review 7.  IL-6 transsignaling: the in vivo consequences.

Authors:  Simon A Jones; Peter J Richards; Jürgen Scheller; Stefan Rose-John
Journal:  J Interferon Cytokine Res       Date:  2005-05       Impact factor: 2.607

8.  Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.

Authors:  G Müller-Newen; A Küster; U Hemmann; R Keul; U Horsten; A Martens; L Graeve; J Wijdenes; P C Heinrich
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

9.  Interleukin-6: a cytokine to forget.

Authors:  D Balschun; W Wetzel; A Del Rey; F Pitossi; H Schneider; W Zuschratter; H O Besedovsky
Journal:  FASEB J       Date:  2004-09-02       Impact factor: 5.191

10.  Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning.

Authors:  C R Pugh; K Kumagawa; M Fleshner; L R Watkins; S F Maier; J W Rudy
Journal:  Brain Behav Immun       Date:  1998-09       Impact factor: 7.217

View more
  25 in total

Review 1.  Posttraumatic stress disorder: A metabolic disorder in disguise?

Authors:  Vasiliki Michopoulos; Aimee Vester; Gretchen Neigh
Journal:  Exp Neurol       Date:  2016-05-28       Impact factor: 5.330

2.  Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex.

Authors:  Francisco Garcia-Oscos; David Peña; Mohammad Housini; Derek Cheng; Diego Lopez; Michael S Borland; Roberto Salgado-Delgado; Humberto Salgado; Santosh D'Mello; Michael P Kilgard; Stefan Rose-John; Marco Atzori
Journal:  Brain Behav Immun       Date:  2014-08-13       Impact factor: 7.217

3.  Microglia priming by interleukin-6 signaling is enhanced in aged mice.

Authors:  Katherine M Garner; Ravi Amin; Rodney W Johnson; Emily J Scarlett; Michael D Burton
Journal:  J Neuroimmunol       Date:  2018-09-10       Impact factor: 3.478

Review 4.  Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins.

Authors:  Ashley Swanson; Tovah Wolf; Alli Sitzmann; Auriel A Willette
Journal:  Behav Brain Res       Date:  2018-02-17       Impact factor: 3.332

5.  The influence of central interleukin-6 on behavioral changes associated with acute alcohol intoxication in adult male rats.

Authors:  Thaddeus M Barney; Andrew S Vore; Anny Gano; Jamie E Mondello; Terrence Deak
Journal:  Alcohol       Date:  2018-11-22       Impact factor: 2.405

6.  IL-6 regulation of synaptic function in the CNS.

Authors:  Donna L Gruol
Journal:  Neuropharmacology       Date:  2014-11-22       Impact factor: 5.250

Review 7.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

8.  Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice.

Authors:  Michael D Burton; Jennifer L Rytych; Gregory G Freund; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2013-01-23       Impact factor: 7.217

9.  Differential effects of acute versus chronic stress on ethanol sensitivity: Evidence for interactions on both behavioral and neuroimmune outcomes.

Authors:  Tamara L Doremus-Fitzwater; Jacqueline E Paniccia; Anny Gano; Andrew S Vore; Terrence Deak
Journal:  Brain Behav Immun       Date:  2018-02-17       Impact factor: 7.217

10.  Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.

Authors:  Madhav Thambisetty; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2014-04       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.